Technical Analysis for OPGN - OpGen, Inc.

Grade Last Price % Change Price Change
B 3.27 2.83% 0.09
OPGN closed up 2.83 percent on Friday, September 17, 2021, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat
Historical OPGN trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
20 DMA Support Bullish 2.83%
New Uptrend Bullish 2.83%
Wide Bands Range Expansion 2.83%
New Downtrend Bearish 4.14%
Crossed Above 20 DMA Bullish 4.14%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 4.14%
Outside Day Range Expansion 4.14%
Older End-of-Day Signals for OPGN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 23 hours ago
Possible Inside Day about 23 hours ago
Down 3% 1 day ago
60 Minute Opening Range Breakdown 1 day ago
Down 2 % 1 day ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

OpGen, Inc. Description

OpGen, Inc. operates as an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections. It offers Acuitas multi-drug-resistant organisms (MDRO) gene test, a molecular screening tool that detects 10 critical MDRO genes from 1 patient swab. The company also provides Acuitas CR Elite Test, which adds the ability to procure a standard microbiological culture result that provides additional information about the identified MDRO gene and its antibiotic susceptibility profile. In addition, it develops Acuitas Lighthouse MDRO bioinformatics product, which focuses on providing MDRO molecular information about an individual patient's resistance profile. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Healthcare Providers Antibiotic Informatics Bacterial Infections Genome Bioinformatics Organisms Veterinary Medicine Bacteria Antimicrobial Resistance Evolutionary Biology Multi Drug Resistant Bacterial Infections

Is OPGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.37
52 Week Low 1.63
Average Volume 1,419,969
200-Day Moving Average 2.42
50-Day Moving Average 2.70
20-Day Moving Average 3.15
10-Day Moving Average 3.28
Average True Range 0.24
ADX 37.54
+DI 23.02
-DI 20.49
Chandelier Exit (Long, 3 ATRs) 2.99
Chandelier Exit (Short, 3 ATRs) 3.14
Upper Bollinger Bands 3.66
Lower Bollinger Band 2.65
Percent B (%b) 0.62
BandWidth 31.99
MACD Line 0.15
MACD Signal Line 0.18
MACD Histogram -0.0362
Fundamentals Value
Market Cap 73.54 Million
Num Shares 22.5 Million
EPS -26.10
Price-to-Earnings (P/E) Ratio -0.13
Price-to-Sales 6.19
Price-to-Book 2.59
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.56
Resistance 3 (R3) 3.52 3.40 3.51
Resistance 2 (R2) 3.40 3.32 3.41 3.49
Resistance 1 (R1) 3.33 3.28 3.37 3.37 3.48
Pivot Point 3.21 3.21 3.22 3.22 3.21
Support 1 (S1) 3.14 3.13 3.18 3.18 3.06
Support 2 (S2) 3.02 3.09 3.03 3.05
Support 3 (S3) 2.95 3.02 3.03
Support 4 (S4) 2.99